Abstract
Coordinated regulation of production and turnover of extracellular matrix (ECM) components is essential for normal tissue homeostasis. The composition of the extracellular matrix can influence cell growth, state of differentiation, and specific gene induction. The multifunctional cytokine transforming growth factor-β (TGF-β) exerts its effects on cell proliferation, differentiation, and migration in part through its modulation of extracellular matrix components. TGF-β promotes net matrix deposition by increasing the expression of specific ECM components such as fibronectin (FN) and collagen, upregulating the expression of inhibitors of ECM proteases, such as plasminogen activator inhibitor-1 (PAI-1) and tissue inhibitors of matrix metaUoproteinases(TIMPs). while simultaneously suppressing the synthesis of proteases, which degrade matrix components, such as interstitial collagenase (reviewed in refs. 1 and 2). TGF-β also induces the expression of cell surface receptors for the ECM, the integrins, which enhance cell-matrix interactions (1,2).
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsSpringer Nature is developing a new tool to find and evaluate Protocols. Learn more
References
Massague J. (1990) The transforming growth factor-β family. Anna. Rev. CeU Biol. 6, 597–641.
Roberts A. B. and Sporn M. B. (1990) The transforming growth factor-βs, in Pep tide Growth Factors and Their Receptors (Sporn M. and Roberts A. B., eds.). Springer-Verlag, Heidelberg, pp. 419–472.
Kornblihtt A. R., Pesce C. G., Alonso C. R., Cramer P., Srebrow A., Werbajh S., and Muro A. F. (1996) The fibronectin gene as a model for splicing and transcription studies. FASEB. J. 10, 248–257.
Hynes R. (1985) Molecular biology of fibronectin. Anna. Rev. Cell Biol. 1, 67–90.
Ignotz R. A. and Massague J. (1986) Transforming growth factor-β stimulates the expression of fibronectin and collagen and their incorporation into the extracellular matrix. J. Biol. Chem. 261, 4337–4345.
Dean D. C, Newby R. F., and Bourgeois S. (1988) Regulation of fibronectin biosynthesis by dexamethasone, transforming growth factor beta, and cAMP in human cell lines. J. CeU Biol. 106, 2159–2170.
Loskutoff D. J., Sawdey M., Keeton M., and Schneiderman J. (1993) Regulation of PAI-1 gene expression in vivo. Thromb. Haemost. 70, 135–137.
Deng G., Cuiriden S. A., Wang S., Rosenberg S., and Loskutoff D. J. (1996) Is plasminogen activator inhibitor-1 the molecular switch that governs urokinase receptor-mediated cell adhesion and release? J. Cell Biol. 134, 1563–1571.
Stefansson S., and Lawrence D. A. (1996) The serpin PAI-1 inhibits cell migration by blocking integrin avβ3 binding to vitronectin. Nature 383, 441–443.
Westerhausen D. R., Jr., Hopkins W. E., and Billadello J. J. (1991) Multiple transforming growth factor-β-indueible elements regulate expression of the plasminogen activator inhibitor type-1 gene in HepG2 cells. J. Biol. Chem. 266, 1092–1100.
Matrisian L. M. (1990) Metalloproteinases and their inhibitors in matrix remodeling. Trends Genet. 6, 121–125.
Mauviel A., Chung K.-Y., Agarwal A., Tamai K., and Uitto J. (1996) Cellspecific induction of distinct oncogenes of the Jun family is responsible for differential regulation of collagenase gene expression by transforming growth factor β in fibroblasts and keratinocytes. J. Biol. Chem. 271, 10,917–10,923.
Kerr L. D., Miller D. B., and Matrisian L. M. (1990) TGF-beta inhibition of transin/stromelysin expression is mediated through a Fos binding sequence. Cell 61, 267–278.
Kubota S., Fridman R., and Yamada Y. (1991) Transforming growth factor-β suppresses the invasiveness of human fibrosarcoma cells in vitro by increasing expression of tissue inhibitor of metalloprotease. Biochem. Biophys. Res. Commun. 176, 129–136.
Salo T., Lyons J. G., Rahemtulla F., Birkedal-Hansen H., and Larjava H. (1991) Transforming growth factor-βl up-regulates type IV collagenase expression in cultured human keratinocytes., J. BioL Chem. 266, 11,436–11,441.
Border W. A. and Noble N. A. (1994) Transforming growth factor (3 in tissue fibrosis. N. Engl J. Med. 331, 1286–1292.
Hocevar B. A. and Howe P. H. (1996) Isolation and characterization of mutant cell lines defective in transforming growth factor beta signaling. Proc. Natl.Acad. Sci. USA 93, 7655–7660.
Shapiro S. D., Fliszar C. J., Broekelmann T. J., Mecham R. P., Senior R. M. and Welgus H. G. (1995) Activation of the 92-kDagelatinase by stromelysin and 4-aminophenylmercuric acetate. J. Bioi. Chem. 270, 6351–6356.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2000 Humana Press Inc.
About this protocol
Cite this protocol
Hocevar, B.A., Howe, P.H. (2000). Analysis of TGFβ-Mediated Synthesis of Extracellular Matrix Components. In: Howe, P.H. (eds) Transforming Growth Factor-Beta Protocols. Methods in Molecular Biology™, vol 142. Humana Press. https://doi.org/10.1385/1-59259-053-5:55
Download citation
DOI: https://doi.org/10.1385/1-59259-053-5:55
Publisher Name: Humana Press
Print ISBN: 978-0-89603-646-8
Online ISBN: 978-1-59259-053-7
eBook Packages: Springer Protocols